☆ 4.2 Article

PROSTVAC® targeted immunotherapy candidate for prostate cancer

IMMUNOTHERAPY (2014)

Get Full Text
Add to Collection

Journal

IMMUNOTHERAPY
Volume 6, Issue 3, Pages 235-247

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/imt.13.176

Keywords

-

Categories

Immunology

Funding

  1. Bavarian Nordic, Inc.

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.